Arvin Yang

2021

In 2021, Arvin Yang earned a total compensation of $869K as Senior Vice President, Chief Medical Officer at Mersana Therapeutics, a 81% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$201,960
Salary$510,000
Other$157,000
Total$868,960

Yang received $510K in salary, accounting for 59% of the total pay in 2021.

Yang also received $202K in non-equity incentive plan and $157K in other compensation.

Rankings

In 2021, Arvin Yang's compensation ranked 9,231st out of 12,415 executives tracked by ExecPay. In other words, Yang earned more than 25.6% of executives.

ClassificationRankingPercentile
All
9,231
out of 12,415
26th
Division
Manufacturing
4,095
out of 5,505
26th
Major group
Chemicals And Allied Products
1,805
out of 2,375
24th
Industry group
Drugs
1,605
out of 2,096
23rd
Industry
Pharmaceutical Preparations
1,190
out of 1,546
23rd

Pay ratio

Arvin Yang's Pay$868,960
Median Employee's Pay$302,642
Pay Ratio

to 1

In 2021, the annual total compensation of Arvin Yang was $868,960.

The annual total compensation of the median employee at Mersana Therapeutics was $302,642.

The ratio of Arvin Yang's pay to the pay of median employee was therefore to one.

Source: SEC filing on April 28, 2023.

Yang's colleagues

We found six more compensation records of executives who worked with Arvin Yang at Mersana Therapeutics in 2021.

2021

Anna Protopapas

Mersana Therapeutics

Chief Executive Officer

2021

Timothy Lowinger

Mersana Therapeutics

Senior Vice President, Chief Science and Technology Officer

2021

Brian DeSchuytner

Mersana Therapeutics

Chief Financial Officer

2021

Michael Kaufman

Mersana Therapeutics

Former Chief Manufacturing Officer

2021

Alejandra Carvajal

Mersana Therapeutics

Chief Legal Officer

2021

Tushar Misra

Mersana Therapeutics

Senior Vice President, Chief Manufacturing Officer

News

You may also like